Cytek Biosciences, Inc.
Ticker: 1831915
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 44.14-15.6% | 52.29+14.7% | 45.60+10.0% | 41.46-19.5% | 51.50+10.5% | 46.62+3.9% | 44.86-6.5% | 48.00 |
| Total Income | 44.14-15.6% | 52.29+14.7% | 45.60+10.0% | 41.46-19.5% | 51.50+10.5% | 46.62+3.9% | 44.86-6.5% | 48.00 |
| EXPENSES | ||||||||
| Expenditure | 62.60+1.8% | 61.49+9.4% | 56.23-0.4% | 56.43+1.2% | 55.75+1.1% | 55.14-0.8% | 55.59+2.1% | 54.42 |
| Tax | 1.49+165.1% | -2.29-92.4% | -1.19-950.0% | 0.14+117.9% | -0.78-124.0% | 3.25+215.2% | -2.82-224.2% | 2.27 |
| PROFIT | ||||||||
| PBT | — | -7.77-14.6% | -6.78+39.8% | -11.27-7143.8% | 0.16+102.2% | -7.19+20.0% | -8.99-114.6% | -4.19 |
| Net Profit | -18.87-244.3% | -5.48+1.8% | -5.58+51.1% | -11.40-1312.8% | 0.94+109.0% | -10.43-69.0% | -6.17+4.5% | -6.46 |
| KEY METRICS | ||||||||
| OPM % | -41.83%-24.25pp | -17.58%+5.72pp | -23.30%+12.82pp | -36.12%-27.87pp | -8.25%+10.04pp | -18.29%+5.64pp | -23.93%-10.55pp | -13.38% |
| NPM % | -42.75%-32.27pp | -10.48%+1.77pp | -12.24%+15.26pp | -27.50%-29.33pp | 1.83%+24.21pp | -22.38%-8.63pp | -13.75%-0.30pp | -13.45% |
Corporate Events
Board MeetingCTKB
202629Jun
Board Meeting
Chief Legal Officer and Corporate Secretary Valerie Barnett'…
SEC Filing ↗ Board MeetingCTKB
202610Jun
Board Meeting
2026 Annual Meeting of Stockholders voting results, includin…
SEC Filing ↗ Board MeetingCTKB
20265Jun
Board Meeting
Philippe Busque resigned as Senior Vice President, Global Sa…
SEC Filing ↗